Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns
Preeclampsia (PE) is a disorder which affects 1-10% of pregnant women worldwide. It is characterised by hypertension and proteinuria in the later stages of gestation and can lead to maternal and perinatal morbidity and mortality. Other than the delivery of the foetus and the removal of the placenta,...
Saved in:
Main Authors: | Maria Portelli, Byron Baron |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Pregnancy |
Online Access: | http://dx.doi.org/10.1155/2018/2632637 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia
by: Sanam Behjat Sasan, et al.
Published: (2017-01-01) -
The Effects of Preeclampsia Severity and Thrombocytopenia on the Prognosis of Hypertensive Pregnant Women
by: Emre Beşe, et al.
Published: (2013-04-01) -
Women's Experiences of Preeclampsia: Australian Action on Preeclampsia Survey of Women and Their Confidants
by: C. East, et al.
Published: (2011-01-01) -
Secondary prevention of preeclampsia
by: Muhammad Ilham Aldika Akbar, et al.
Published: (2025-02-01) -
Preeclampsia Prediction and Management
by: Irene Rebelo, et al.
Published: (2014-01-01)